Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum
The Symposium provides a forum for the presentation and discussion of the established facts and open questions concerning the use of low-dose aspirin for the primary and secondary prevention of atherothrombosis, as reviewed by leading experts from China, Europe and USA, with a view at identifying similarities and discrepancies among the different approaches to prevention.